New potential key pathway in patients with ALL

At the 2022 ASH Conference in December, a study was presented that focuses on uncovering key pathways in leukemic-stromal cells through Leukemia-Derived Extracellular Vesicles (LEV) in patients with acute lymphoblastic leukemia (ALL). MD and PhD Signe Modvig from Rigshospitalet in Denmark discussed the findings of this study in this MEDtalk.